Doug Williams, new Sana R&D chief (Codiak website)
April 10, 2023 04:05 PM EDT
People
Bioregnum

In a bit­ter­sweet tran­si­tion, Doug Williams takes on his next big biotech chal­lenge

Doug Williams is mov­ing on.

Just days af­ter sound­ing taps in bank­rupt­cy court over Co­di­ak Bio­Sciences, where he helped spear­head the work as CEO …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
ENDPOINTS CAREERS

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Trump asks 'very tough hom­bre' Dr. Oz to lead MFN talks

US warns drug­mak­ers against mis­rep­re­sent­ing cost of im­port­ed prod­ucts

Meet the ‘first sale’ rule: A cus­toms loop­hole phar­ma com­pa­nies could use to ease tar­iff im­pact

About 5% of CBER and CDER left af­ter FDA staff cuts, analy­sis finds

End­points 100 biotech sur­vey: Wel­come to the sum­mer of biotech’s dis­con­tent

sponsored

Does your sup­ply chain hold up un­der pres­sure for high-risk tem­per­a­ture-crit­i­cal ship­ments?

A service from the Financial Times